49 related articles for article (PubMed ID: 25977220)
1. LKB1 Inactivation Promotes ROS-Induced Plasticity in NSCLC.
Cancer Discov; 2015 Jul; 5(7):OF22. PubMed ID: 25977220
[TBL] [Abstract][Full Text] [Related]
2. LKB1 Inactivation Elicits a Redox Imbalance to Modulate Non-small Cell Lung Cancer Plasticity and Therapeutic Response.
Li F; Han X; Li F; Wang R; Wang H; Gao Y; Wang X; Fang Z; Zhang W; Yao S; Tong X; Wang Y; Feng Y; Sun Y; Li Y; Wong KK; Zhai Q; Chen H; Ji H
Cancer Cell; 2015 May; 27(5):698-711. PubMed ID: 25936644
[TBL] [Abstract][Full Text] [Related]
3. LKB1 inactivation sensitizes non-small cell lung cancer to pharmacological aggravation of ER stress.
Inge LJ; Friel JM; Richer AL; Fowler AJ; Whitsett T; Smith MA; Tran NL; Bremner RM
Cancer Lett; 2014 Oct; 352(2):187-95. PubMed ID: 25011082
[TBL] [Abstract][Full Text] [Related]
4. cAMP/CREB-regulated LINC00473 marks LKB1-inactivated lung cancer and mediates tumor growth.
Chen Z; Li JL; Lin S; Cao C; Gimbrone NT; Yang R; Fu DA; Carper MB; Haura EB; Schabath MB; Lu J; Amelio AL; Cress WD; Kaye FJ; Wu L
J Clin Invest; 2016 Jun; 126(6):2267-79. PubMed ID: 27140397
[TBL] [Abstract][Full Text] [Related]
5. The CREB coactivator CRTC2 promotes oncogenesis in LKB1-mutant non-small cell lung cancer.
Rodón L; Svensson RU; Wiater E; Chun MGH; Tsai WW; Eichner LJ; Shaw RJ; Montminy M
Sci Adv; 2019 Jul; 5(7):eaaw6455. PubMed ID: 31355336
[TBL] [Abstract][Full Text] [Related]
6. Transdifferentiation of lung adenocarcinoma in mice with Lkb1 deficiency to squamous cell carcinoma.
Han X; Li F; Fang Z; Gao Y; Li F; Fang R; Yao S; Sun Y; Li L; Zhang W; Ma H; Xiao Q; Ge G; Fang J; Wang H; Zhang L; Wong KK; Chen H; Hou Y; Ji H
Nat Commun; 2014; 5():3261. PubMed ID: 24531128
[TBL] [Abstract][Full Text] [Related]
7. Metformin enhances cisplatin cytotoxicity by suppressing signal transducer and activator of transcription-3 activity independently of the liver kinase B1-AMP-activated protein kinase pathway.
Lin CC; Yeh HH; Huang WL; Yan JJ; Lai WW; Su WP; Chen HH; Su WC
Am J Respir Cell Mol Biol; 2013 Aug; 49(2):241-50. PubMed ID: 23526220
[TBL] [Abstract][Full Text] [Related]
8. Enhanced antitumor effect of cisplatin in human NSCLC cells by tumor suppressor LKB1.
Ou W; Ye S; Yang W; Wang Y; Ma Q; Yu C; Shi H; Yuan Z; Zhong G; Ren J; Zhu W; Wei Y
Cancer Gene Ther; 2012 Jul; 19(7):489-98. PubMed ID: 22576699
[TBL] [Abstract][Full Text] [Related]
9. Hypoxia-inducible factor 1α (HIF-1α) and reactive oxygen species (ROS) mediates radiation-induced invasiveness through the SDF-1α/CXCR4 pathway in non-small cell lung carcinoma cells.
Gu Q; He Y; Ji J; Yao Y; Shen W; Luo J; Zhu W; Cao H; Geng Y; Xu J; Zhang S; Cao J; Ding WQ
Oncotarget; 2015 May; 6(13):10893-907. PubMed ID: 25843954
[TBL] [Abstract][Full Text] [Related]
10. Depletion of end-binding protein 1 (EB1) promotes apoptosis of human non-small-cell lung cancer cells via reactive oxygen species and Bax-mediated mitochondrial dysfunction.
Kim MJ; Yun HS; Hong EH; Lee SJ; Baek JH; Lee CW; Yim JH; Kim JS; Park JK; Um HD; Hwang SG
Cancer Lett; 2013 Oct; 339(1):15-24. PubMed ID: 23900080
[TBL] [Abstract][Full Text] [Related]
11. [Effect of small interfering RNA-induced LKB1 gene silencing on the biological behavior of lung carcinoma cells].
Liang X; Nan KJ; Xu QZ
Nan Fang Yi Ke Da Xue Xue Bao; 2007 Sep; 27(9):1303-6. PubMed ID: 17884763
[TBL] [Abstract][Full Text] [Related]
12. L1 cell adhesion molecule promotes tumorigenicity and metastatic potential in non-small cell lung cancer.
Hai J; Zhu CQ; Bandarchi B; Wang YH; Navab R; Shepherd FA; Jurisica I; Tsao MS
Clin Cancer Res; 2012 Apr; 18(7):1914-24. PubMed ID: 22307136
[TBL] [Abstract][Full Text] [Related]
13. Erlotinib activates mitochondrial death pathways related to the production of reactive oxygen species in the human non-small cell lung cancer cell line A549.
Qian X; Li J; Ding J; Wang Z; Zhang W; Hu G
Clin Exp Pharmacol Physiol; 2009 May; 36(5-6):487-94. PubMed ID: 19673930
[TBL] [Abstract][Full Text] [Related]
14. Serum and glucocorticoid kinase 1 promoted the growth and migration of non-small cell lung cancer cells.
Xiaobo Y; Qiang L; Xiong Q; Zheng R; Jianhua Z; Zhifeng L; Yijiang S; Zheng J
Gene; 2016 Jan; 576(1 Pt 2):339-46. PubMed ID: 26548813
[TBL] [Abstract][Full Text] [Related]
15. The transmembrane adaptor Cbp/PAG1 controls the malignant potential of human non-small cell lung cancers that have c-src upregulation.
Kanou T; Oneyama C; Kawahara K; Okimura A; Ohta M; Ikeda N; Shintani Y; Okumura M; Okada M
Mol Cancer Res; 2011 Jan; 9(1):103-14. PubMed ID: 21156787
[TBL] [Abstract][Full Text] [Related]
16. Somatic alterations of the serine/threonine kinase LKB1 gene in squamous cell (SCC) and large cell (LCC) lung carcinoma.
Strazisar M; Mlakar V; Rott T; Glavac D
Cancer Invest; 2009 May; 27(4):407-16. PubMed ID: 19229701
[TBL] [Abstract][Full Text] [Related]
17. Nicotine stimulates human lung cancer cell growth by inducing fibronectin expression.
Zheng Y; Ritzenthaler JD; Roman J; Han S
Am J Respir Cell Mol Biol; 2007 Dec; 37(6):681-90. PubMed ID: 17600315
[TBL] [Abstract][Full Text] [Related]
18. Disruption of BASIGIN decreases lactic acid export and sensitizes non-small cell lung cancer to biguanides independently of the LKB1 status.
Granja S; Marchiq I; Le Floch R; Moura CS; Baltazar F; Pouysségur J
Oncotarget; 2015 Mar; 6(9):6708-21. PubMed ID: 25894929
[TBL] [Abstract][Full Text] [Related]
19. DDX5 promotes proliferation and tumorigenesis of non-small-cell lung cancer cells by activating β-catenin signaling pathway.
Wang Z; Luo Z; Zhou L; Li X; Jiang T; Fu E
Cancer Sci; 2015 Oct; 106(10):1303-12. PubMed ID: 26212035
[TBL] [Abstract][Full Text] [Related]
20. Analysis of lncRNA expression profiles in non-small cell lung cancers (NSCLC) and their clinical subtypes.
Yang J; Lin J; Liu T; Chen T; Pan S; Huang W; Li S
Lung Cancer; 2014 Aug; 85(2):110-5. PubMed ID: 24906504
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
